# Dr.Oracle vs ValueSense

Dr.Oracle records 723,847 monthly visits with -1.2% month-over-month growth and Free Trial pricing. ValueSense records 8,984 monthly visits with -25.4% growth and Freemium pricing.

| Metric | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | [ValueSense](https://openaitools.app/tool/valuesense) |
| :--- | :--- | :--- |
| Website URL | https://droracle.ai | https://valuesense.io |
| Categories | AI Healthcare, AI Medical Diagnosis, AI Assistant, AI Answer | AI Investing, AI For Finance, AI Stock Trading, AI Research Tool |
| Pricing Model | Free Trial | Freemium |
| Monthly Visits | 723,847 | 8,984 |
| MoM Growth Rate | -1.2% | -25.4% |
| Primary Market | United States | United States |
| Direct Visits | 86,675 | 3,654 |
| Review Score | 4.3 | 4.2 |
| Saved Count | 2 | 0 |
| Supported Platforms | Website | Website |

## Dr.Oracle

Dr.Oracle is a medical AI platform built for healthcare professionals and trainees who need fast, reliable answers they can verify. Users pose a clinical question in plain language — a patient scenario, a drug interaction, or a diagnostic dilemma — and receive a structured explanation drawn from international guidelines and clinical research, with references listed at the end of each answer so the reasoning can be checked against the source.

The platform maintains its own internal clinical guideline articles written and updated by a multidisciplinary editorial team, and states that it does not use AI to generate that core knowledge base. Answers are regularly reviewed by a Medical Advisory Board, the questions are treated as anonymous and stripped of identifying information, and the company reports that it accepts no pharmaceutical funding. Coverage spans essentially every specialty, from cardiology and oncology to emergency medicine, pediatrics, and OB/GYN.

Beyond direct Q&A, Dr.Oracle supports differential diagnosis from patient findings, pre-rounding and clinical presentation practice for students, and a Research Mode for evaluating the strengths and weaknesses of up to 25 papers at once. It reports top scores on the USMLE exams across all three steps in its own published studies, and is available as a web app plus iOS and Android apps. Note that this is a clinical reference and education tool, not a replacement for professional medical judgment.

**Pricing & Plans:** Dr.Oracle offers a free trial and is free to start; the site promotes trying it for free and provides subscription options through its apps. Check the official site and app stores for current plan pricing.

- **Cited guideline answers:** Every response links to the guidelines and peer-reviewed literature behind it, so clinicians can verify the evidence before acting.
- **Differential diagnosis support:** Enter patient findings and get a comprehensive differential to help avoid cognitive bias and missed diagnoses.
- **Research Mode:** Rapidly evaluate the strengths and weaknesses of up to 25 papers at once to speed up literature review and publishing work.
- **Physician-written knowledge base:** Internal guideline articles are authored and continuously updated by practicing physicians rather than generated by AI.
- **USMLE and clerkship prep:** Study alongside question banks to deepen understanding and practice expert-level clinical presentations.

**Strengths:** Answers come with verifiable citations to guidelines and literature; Knowledge base is physician-written with Medical Advisory Board review; Covers all major medical specialties and international guidelines; Includes dedicated tools for differential diagnosis and research appraisal

**Limitations:** Not a substitute for professional clinical judgment or patient-specific evaluation; Best value requires a subscription after the trial; Reported exam benchmark scores come from the vendor's own studies

[Profile (Markdown)](https://openaitools.app/tool/dr-oracle.md)

## ValueSense

ValueSense is a stock analysis platform built for value-oriented investors who want hedge-fund-style analytics without a hedge-fund budget. It pulls valuation models, screeners, quality metrics and market signals into a single workspace, so you can move from idea generation to deeper research without juggling ten different tabs. The core premise is intrinsic value: rather than chasing price momentum, ValueSense helps you estimate what a business is worth and compare that estimate against the market.

The toolkit centers on intrinsic-value calculators — reverse DCF, DCF, Peter Lynch fair value and earnings power value — alongside a stock screener with AI filters and backtesting, quality ratings, AI earnings analysis, a stock heatmap, an insiders tracker and super-investor profiles. A stock ideas section surfaces 360+ automated ideas across categories such as moat stocks, quality growers and undervalued small caps, giving you a running start on research.

ValueSense also includes a portfolio tracker and earnings calendar so you can monitor holdings and catalysts in the same place. Plans run from a free starting tier up to Explorer, Pro and Enterprise levels, with the more advanced tools and premium ideas unlocked at higher tiers. The company stresses that ValueSense is a data and analytics provider, not a broker or adviser, so any investment decision remains your own.

**Pricing & Plans:** ValueSense uses a tiered model: a free starting tier plus paid Explorer and Pro plans, with an Enterprise option. Higher tiers unlock more intrinsic value tools, screening, stock ideas and data. See the pricing page for current details.

- **Intrinsic value toolkit:** Work with reverse DCF, DCF, Peter Lynch fair value and earnings power value to estimate what a stock is really worth before buying.
- **AI stock screener with backtesting:** Filter the market with AI-driven presets and custom filters, and backtest screens to see how they would have performed.
- **Curated stock ideas:** Browse 360+ automated stock ideas across categories like moat stocks, quality grower and undervalued names, refreshed regularly.
- **Insiders and super investors:** Track super-investor portfolios and insider buying and selling to see where informed money is moving.
- **Portfolio and market dashboards:** Monitor holdings with a portfolio tracker, earnings calendar, stock heatmap, charts and quality ratings in one place.

**Strengths:** Combines valuation tools, screeners and signals in one workspace; Strong focus on intrinsic value rather than price momentum; AI-powered screener with backtesting and presets; Insider and super-investor tracking for idea generation

**Limitations:** Geared toward fundamentally-minded investors, less suited to pure day-trading or technical-only strategies; The richest tools and premium stock ideas sit behind higher-tier plans; It is a data and analytics service, not a broker, so you cannot execute trades inside it; Reliable intrinsic value estimates still require you to interpret assumptions and inputs

[Profile (Markdown)](https://openaitools.app/tool/valuesense.md)

## Frequently Asked Questions

### How do Dr.Oracle and ValueSense compare in monthly traffic?

Dr.Oracle has 723,847 monthly visits, while ValueSense has 8,984. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Dr.Oracle has a month-over-month growth rate of -1.2%; ValueSense has -25.4%.

### How does pricing compare?

Dr.Oracle: Free Trial. Dr.Oracle offers a free trial and is free to start; the site promotes trying it for free and provides subscription options through its apps. Check the official site and app stores for current plan pricing. ValueSense: Freemium. ValueSense uses a tiered model: a free starting tier plus paid Explorer and Pro plans, with an Enterprise option. Higher tiers unlock more intrinsic value tools, screening, stock ideas and data. See the pricing page for current details.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [ChatGPT](https://openaitools.app/tool/chatgpt-4) | 6,048,022,723 | +2.2% | Freemium | OpenAI's flagship multimodal assistant powered by GPT-6 and GPT-5.6 for reasoning, coding, and deep research. | [.md](https://openaitools.app/tool/chatgpt-4.md) |
| 2 | [Perplexity](https://openaitools.app/tool/perplexity-ai) | 88,310,223 | -3.7% | Freemium | Real-time AI answer engine and research workspace combining live web citations with frontier reasoning models. | [.md](https://openaitools.app/tool/perplexity-ai.md) |
| 3 | [Consensus](https://openaitools.app/tool/consensus) | 6,014,388 | -1.2% | Freemium | Searches peer-reviewed scientific literature for evidence-based answers, but lacks dedicated medical diagnosis and clinical case tools. | [.md](https://openaitools.app/tool/consensus.md) |
| 4 | [Ubie](https://openaitools.app/tool/ubie) | 2,941,054 | -23.2% | Free | Free AI symptom checker developed by doctors | [.md](https://openaitools.app/tool/ubie.md) |
| 5 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | AI research assistant for evidence-based literature review and synthesis | [.md](https://openaitools.app/tool/elicit.md) |
| 6 | [Aime](https://openaitools.app/tool/aime) | 260,428 | +11.4% | Freemium | AI investing copilot for stock research, screening and market signals | [.md](https://openaitools.app/tool/aime.md) |
| 7 | [Danelfin](https://openaitools.app/tool/danelfin-com) | 216,830 | -11.1% | Freemium | AI-driven stock scores that rank every pickable stock by probability of beating the market | [.md](https://openaitools.app/tool/danelfin-com.md) |
| 8 | [MediSearch](https://openaitools.app/tool/medisearch) | 216,014 | -0.5% | Free | Provides evidence-based medical answers with scientific citations, but functions more as a search engine than a clinical workflow tool. | [.md](https://openaitools.app/tool/medisearch.md) |
| 9 | [Intellectia.Ai](https://openaitools.app/tool/intellectia-ai) | 171,347 | +18% | Free Trial, Paid | AI-driven market analysis for faster, data-backed investing decisions | [.md](https://openaitools.app/tool/intellectia-ai.md) |
| 10 | [0xmd](https://openaitools.app/tool/0xmd-com) | 128,262 | -2.2% | Freemium | Interprets medical reports and answers health questions using specialized models, but has a smaller clinical feature set. | [.md](https://openaitools.app/tool/0xmd-com.md) |

---
Source: https://openaitools.app/compare/dr-oracle-vs-valuesense

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)